These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32351454)

  • 21. Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1).
    Lairmore TC; Piersall LD; DeBenedetti MK; Dilley WG; Mutch MG; Whelan AJ; Zehnbauer B
    Ann Surg; 2004 May; 239(5):637-45; discussion 645-7. PubMed ID: 15082967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing.
    Ellard S; Hattersley AT; Brewer CM; Vaidya B
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):169-75. PubMed ID: 15670192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome.
    Cuevas-Ocampo AK; Bollen AW; Goode B; Pajtler KW; Chavez L; Sharma T; Dai SC; McDermott M; Perry A; Korshunov A; Solomon DA
    Acta Neuropathol; 2017 Apr; 133(4):661-663. PubMed ID: 28238068
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Missense Mutation of the MEN1 Gene in a Patient with Multiple Endocrine Neoplasia Type 1 with Glucagonoma and Obesity.
    Murakami T; Usui T; Nakajima A; Mochida Y; Saito S; Nambu T; Kato T; Matsuda Y; Yonemitsu S; Muro S; Oki S
    Intern Med; 2015; 54(19):2475-81. PubMed ID: 26424307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases.
    Tham E; Grandell U; Lindgren E; Toss G; Skogseid B; Nordenskjöld M
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3389-95. PubMed ID: 17623761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Menin mutations in the diagnosis and prediction of multiple endocrine neoplasia type 1.
    Karges W; Ludwig L; Kessler H; Wissmann A; Wagner PK; Boehm BO
    Langenbecks Arch Surg; 1998 Apr; 383(2):183-6. PubMed ID: 9641896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A
    Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual presentation of multiple endocrine neoplasia type 1 in a young woman with a novel mutation of the MEN1 gene.
    Balogh K; Patócs A; Majnik J; Varga F; Illyés G; Hunyady L; Rácz K
    J Hum Genet; 2004; 49(7):380-386. PubMed ID: 15205994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients.
    de Laat JM; van der Luijt RB; Pieterman CR; Oostveen MP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
    BMC Med; 2016 Nov; 14(1):182. PubMed ID: 27842554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population.
    Romanet P; Mohamed A; Giraud S; Odou MF; North MO; Pertuit M; Pasmant E; Coppin L; Guien C; Calender A; Borson-Chazot F; Béroud C; Goudet P; Barlier A
    J Clin Endocrinol Metab; 2019 Mar; 104(3):753-764. PubMed ID: 30339208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1).
    Karges W; Schaaf L; Dralle H; Boehm BO
    Exp Clin Endocrinol Diabetes; 2000; 108(5):334-40. PubMed ID: 10989951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
    Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of MEN1 c.482G>A (p.Gly161Asp) mutation in a pedigree with familial multiple endocrine neoplasia type 1.
    Luo Y; Sun Y; Zhu X; Li X
    Mol Med Rep; 2017 Dec; 16(6):8973-8976. PubMed ID: 29039523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors.
    Vannucci L; Marini F; Giusti F; Ciuffi S; Tonelli F; Brandi ML
    Endocrine; 2018 Feb; 59(2):438-448. PubMed ID: 28530019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple endocrine neoplasia type 1.
    Pannett AA; Thakker RV
    Endocr Relat Cancer; 1999 Dec; 6(4):449-73. PubMed ID: 10730900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple endocrine neoplasia 1: providing care for the family.
    Mahon SM; Waldman L
    Clin J Oncol Nurs; 2010 Oct; 14(5):657-60. PubMed ID: 20880824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for MEN1 mutations in patients with atypical endocrine neoplasia.
    Dackiw AP; Cote GJ; Fleming JB; Schultz PN; Stanford P; Vassilopoulou-Sellin R; Evans DB; Gagel RF; Lee JE
    Surgery; 1999 Dec; 126(6):1097-103; discussion 1103-4. PubMed ID: 10598193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel frameshift c.930delG MEN1 germline mutation (p.Glu273LysfsTer7) in a sporadic case of multiple endocrine neoplasia type 1: A case report.
    Naruse H; Umemura H; Nakayama T
    Mol Med Rep; 2020 Dec; 22(6):5423-5427. PubMed ID: 33173995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.
    Lourenço DM; Toledo RA; Mackowiak II; Coutinho FL; Cavalcanti MG; Correia-Deur JE; Montenegro F; Siqueira SA; Margarido LC; Machado MC; Toledo SP
    Eur J Endocrinol; 2008 Sep; 159(3):259-74. PubMed ID: 18524795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.